Vision
To build innovative healthcare and biomedical companies that result in impactful patient outcomes.
Backing the best Health and Biomedical ventures of tomorrow
About Us
Coronet Ventures is the Singapore-based venture entity of Cedars-Sinai Intellectual Property Company (CSIP). We identify and invest in early-stage healthcare and biomedical science startups in Singapore. The first international investment operation for CSIP, Coronet Ventures is focused on solutions that are aimed at the U.S. market and that are synergistic with Cedars-Sinai’s areas of excellence.
Mission
To nurture healthcare companies that advance Cedars-Sinai's mission of delivering quality healthcare and CSIP's mission of intellectual property commercialization.
Why Coronet?
US Market Entry
The U.S. accounts for nearly 50% of global healthcare expenditures. We offer you a landing pad in the U.S. through our affiliation with Cedars-Sinai, as well as the chance to launch your solutions in other hospitals and clinics in the Cedars-Sinai health system. The timing could not be better for you to make your mark on the U.S. healthcare industry.
Clinical Ecosystem
You will gain access to relevant clinical experts from Cedars-Sinai Medical Center who can help you validate your solutions in a clinical setting and champion your cause to stakeholders in our ecosystem. Running a clinical trial across our sites becomes easier once you become part of Cedars-Sinai’s clinical ecosystem and understand its requirements.
Startup Support Ecosystem
Cedars-Sinai launched its Accelerator program in 2017. Since then, over 80 companies from around the world have experienced our three-month bootcamp. It has helped both Cedars-Sinai and our companies make tangible impacts on patient care. As a Coronet Ventures investee, you will have access to the Cedars-Sinai Accelerator’s network of alumni startups who can help you on your journey. At the same time, our internal and external mentors will be there to guide you. In addition, Cedars-Sinai’s technology transfer office can support you in protecting your intellectual property, filing your FDA submissions, and licensing and commercializing your technology.
Team
Nirdesh Gupta, PhD
Chief Executive Officer
Colin Tan
Investment Director
Board
David Wrigley
Executive Vice President & Chief Financial Officer
CEdars-Sinai Health System
James Laur
President
Cedars Sinai Intellectual Property Company
Edward Prunchunas
Board Member
Cedars Sinai Intellectual property company
Investment strategy
Investment Stage
Seed to Series A
Cheque size
US$500K - $6M